Big Move For Rocket Pharmaceuticals, Inc.
Wed, Sep 13, 2023 at 07:21 PM
Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ) rocketted at $21.23, a gain of 38.8%. On Wed, Sep 13, 2023, RCKT:NASDAQ hit a New 2-Week High of $21.23. The stock appeared on our News Catalysts scanner on Wed, Sep 13, 2023 at 01:05 PM in the 'MISCELLANEOUS' category. From Wed, Aug 30, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days
About Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ)
Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.
Top 10 Gainers:
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 81.13%
- ZyVersa Therapeutics Inc Com Stk (ZVSA:NASDAQ), 47.86%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 44.98%
- BitNile Metaverse Inc Com (New) (BNMV:NASDAQ), 44.31%
- Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ), 38.85%
- SRAX, Inc. (SRAX:NASDAQ), 33.33%
- DASAN Zhone Solutions, Inc. (DZSI:NASDAQ), 32.24%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 31.96%
- SHF Holdings Inc Cl A (SHFS:NASDAQ), 25.68%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 25.13%